FDA-Drug2019-03-20Class III
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Hazard
Failed Dissolution Specifications
Sold states
Nationwide, including Puerto Rico.
Affected count
14,448 bottles
Manufactured in
1101 C Ave W, N/A, Seymour, IN, United States
Products
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0996-2019More Lannett Company Inc. recalls
- FDA-Drug2026-07-08Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
- FDA-Drug2026-05-27Lannett Primidone Tablets 250mg recalled for Acemetacin contamination
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief